通过论文及专利的交叉引用分析探讨合成生物学领域基础研究与技术创新的关联,为提高该领域基础研究及技术创新能力提供建议,为科技资源整合策略提供支持。本研究以论文、专利分别作为基础研究与技术创新的替代指标,以Web of Science和...通过论文及专利的交叉引用分析探讨合成生物学领域基础研究与技术创新的关联,为提高该领域基础研究及技术创新能力提供建议,为科技资源整合策略提供支持。本研究以论文、专利分别作为基础研究与技术创新的替代指标,以Web of Science和美国专利商标局中收录的近十年合成生物学领域共9033篇论文、5233件专利为研究对象,从引文整体分布情况、科学及技术关联度、引文时滞、循环周期四个角度对专利及论文引文进行分析,从主题分布情况对论文-专利混合共被引情况进行分析,力求多角度综合分析合成生物学领域基础研究与技术创新之间关联关系。研究结果表明,国际上合成生物学领域97%左右的技术创新引用了基础研究的理论成果,但仅有4%的基础研究引用了技术创新成果;科学关联度总体波动不大,而技术关联度尚未形成稳定的趋势,美国的科学关联度及技术关联度均优于其他国家,而我国较为落后;专利文献更倾向引用时滞小于15年的专利、小于13年的论文,论文文献更倾向引用时滞小于6年的专利、小于6年的论文;专利的技术循环周期为13.92年、科学循环周期为12.28年,论文的科学循环周期为6.99年、技术循环周期为10.85年;合成生物学领域基础研究与技术创新有相同的发展趋势,如均关注基因与基因组的合成、基因编辑等方面的研究,但基础研究关注范围更多、领域更广。因此未来需加强将技术创新成果运用到基础研究中,促进新的技术创新成果产出;加快基础研究及先前技术创新成果向技术创新的转化速度;引用新颖性更强的基础研究及技术创新成果,促进创新。展开更多
Synthetic biology is capable of delivering new solutions to key challenges spanning the bioeconomy,both nationally and internationally.Recognising this significant potential and the associated need to facilitate its t...Synthetic biology is capable of delivering new solutions to key challenges spanning the bioeconomy,both nationally and internationally.Recognising this significant potential and the associated need to facilitate its translation and commercialisation the UK government commissioned the production of a national Synthetic Biology Roadmap in 2011,and subsequently provided crucial support to assist its implementation.Critical infrastructural investments have been made,and important strides made towards the development of an effectively connected community of practitioners and interest groups.A number of Synthetic Biology Research Centres,DNA Synthesis Foundries,a Centre for Doctoral Training,and an Innovation Knowledge Centre have been established,creating a nationally distributed and integrated network of complementary facilities and expertise.The UK Synthetic Biology Leadership Council published a UK Synthetic Biology Strategic Plan in 2016,increasing focus on the processes of translation and commercialisation.Over 50 start-ups,SMEs and larger companies are actively engaged in synthetic biology in the UK,and inward investments are starting to flow.Together these initiatives provide an important foundation for stimulating innovation,actively contributing to international research and development partnerships,and helping deliver useful benefits from synthetic biology in response to local and global needs and challenges.展开更多
文摘通过论文及专利的交叉引用分析探讨合成生物学领域基础研究与技术创新的关联,为提高该领域基础研究及技术创新能力提供建议,为科技资源整合策略提供支持。本研究以论文、专利分别作为基础研究与技术创新的替代指标,以Web of Science和美国专利商标局中收录的近十年合成生物学领域共9033篇论文、5233件专利为研究对象,从引文整体分布情况、科学及技术关联度、引文时滞、循环周期四个角度对专利及论文引文进行分析,从主题分布情况对论文-专利混合共被引情况进行分析,力求多角度综合分析合成生物学领域基础研究与技术创新之间关联关系。研究结果表明,国际上合成生物学领域97%左右的技术创新引用了基础研究的理论成果,但仅有4%的基础研究引用了技术创新成果;科学关联度总体波动不大,而技术关联度尚未形成稳定的趋势,美国的科学关联度及技术关联度均优于其他国家,而我国较为落后;专利文献更倾向引用时滞小于15年的专利、小于13年的论文,论文文献更倾向引用时滞小于6年的专利、小于6年的论文;专利的技术循环周期为13.92年、科学循环周期为12.28年,论文的科学循环周期为6.99年、技术循环周期为10.85年;合成生物学领域基础研究与技术创新有相同的发展趋势,如均关注基因与基因组的合成、基因编辑等方面的研究,但基础研究关注范围更多、领域更广。因此未来需加强将技术创新成果运用到基础研究中,促进新的技术创新成果产出;加快基础研究及先前技术创新成果向技术创新的转化速度;引用新颖性更强的基础研究及技术创新成果,促进创新。
文摘Synthetic biology is capable of delivering new solutions to key challenges spanning the bioeconomy,both nationally and internationally.Recognising this significant potential and the associated need to facilitate its translation and commercialisation the UK government commissioned the production of a national Synthetic Biology Roadmap in 2011,and subsequently provided crucial support to assist its implementation.Critical infrastructural investments have been made,and important strides made towards the development of an effectively connected community of practitioners and interest groups.A number of Synthetic Biology Research Centres,DNA Synthesis Foundries,a Centre for Doctoral Training,and an Innovation Knowledge Centre have been established,creating a nationally distributed and integrated network of complementary facilities and expertise.The UK Synthetic Biology Leadership Council published a UK Synthetic Biology Strategic Plan in 2016,increasing focus on the processes of translation and commercialisation.Over 50 start-ups,SMEs and larger companies are actively engaged in synthetic biology in the UK,and inward investments are starting to flow.Together these initiatives provide an important foundation for stimulating innovation,actively contributing to international research and development partnerships,and helping deliver useful benefits from synthetic biology in response to local and global needs and challenges.
